168 related articles for article (PubMed ID: 34790401)
21. Contrast-enhanced ultrasound algorithm (ACR CEUS LI-RADSv 2017)- a valuable tool for the noninvasive diagnosis of hepatocellular carcinoma in patients with chronic liver disease.
Ghiuchici AM; Dănilă M; Popescu A; Șirli R; Moga T; Topan M; Bende F; Sporea I
Med Ultrason; 2021 Nov; 23(4):383-389. PubMed ID: 33793696
[TBL] [Abstract][Full Text] [Related]
22. Contrast-Enhanced Ultrasound: a Simple and Effective Tool in Defining a Rapid Diagnostic Work-up for Small Nodules Detected in Cirrhotic Patients during Surveillance.
Giorgio A; Montesarchio L; Gatti P; Amendola F; Matteucci P; Santoro B; Merola MG; Merola F; Coppola C; Giorgio V
J Gastrointestin Liver Dis; 2016 Jun; 25(2):205-11. PubMed ID: 27308652
[TBL] [Abstract][Full Text] [Related]
23. PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients.
Saitta C; Raffa G; Alibrandi A; Brancatelli S; Lombardo D; Tripodi G; Raimondo G; Pollicino T
Medicine (Baltimore); 2017 Jun; 96(26):e7266. PubMed ID: 28658121
[TBL] [Abstract][Full Text] [Related]
24. Differentiation of regenerative nodule, dysplastic nodule, and small hepatocellular carcinoma in cirrhotic patients: a contrast-enhanced ultrasound-based multivariable model analysis.
Duan Y; Xie X; Li Q; Mercaldo N; Samir AE; Kuang M; Lin M
Eur Radiol; 2020 Sep; 30(9):4741-4751. PubMed ID: 32307563
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
Forner A; Vilana R; Ayuso C; Bianchi L; Solé M; Ayuso JR; Boix L; Sala M; Varela M; Llovet JM; Brú C; Bruix J
Hepatology; 2008 Jan; 47(1):97-104. PubMed ID: 18069697
[TBL] [Abstract][Full Text] [Related]
26. Imaging detection of new HCCs in cirrhotic patients treated with different techniques: Comparison of conventional US, spiral CT, and 3-dimensional contrast-enhanced US with the Navigator technique (Nav 3D CEUS)().
Giangregorio F; Comparato G; Marinone MG; Di Stasi M; Sbolli G; Aragona G; Tansini P; Fornari F
J Ultrasound; 2009 Mar; 12(1):12-21. PubMed ID: 23397019
[TBL] [Abstract][Full Text] [Related]
27. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
[TBL] [Abstract][Full Text] [Related]
28. Imaging Features of Hepatocellular Carcinoma in the Non-Cirrhotic Liver with Sonazoid-Enhanced Contrast-Enhanced Ultrasound.
Chen S; Qiu YJ; Zuo D; Shi SN; Wang WP; Dong Y
Diagnostics (Basel); 2022 Sep; 12(10):. PubMed ID: 36291962
[TBL] [Abstract][Full Text] [Related]
29. Contrast-Enhanced Ultrasound Findings and Differential Diagnosis of Hepatic Epithelioid Angiomyolipoma Compared with Hepatocellular Carcinoma.
Huang Z; Wu X; Li S; Li K
Ultrasound Med Biol; 2020 Jun; 46(6):1403-1411. PubMed ID: 32165015
[TBL] [Abstract][Full Text] [Related]
30. Contrast-Enhanced Ultrasound to Monitor Early Recurrence of Primary Hepatocellular Carcinoma after Curative Treatment.
Liu LF; Ding ZL; Zhong JH; Li HX; Liu JJ; Li H; Li LQ
Biomed Res Int; 2018; 2018():8910562. PubMed ID: 30533441
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic efficacy of contrast-enhanced ultrasound versus MRI Liver Imaging Reporting and Data System (LI-RADS) for categorising hepatic observations in patients at risk of hepatocellular carcinoma.
Li S; Zhou L; Chen R; Chen Y; Niu Z; Qian L; Fang Y; Xu L; Xu H; Zhang L
Clin Radiol; 2021 Feb; 76(2):161.e1-161.e10. PubMed ID: 33198943
[TBL] [Abstract][Full Text] [Related]
32. Liver Stiffness and Serum Alpha-Fetoprotein in Discriminating Small Hepatocellular Carcinoma from Cirrhotic Nodule.
Li JW; Ling WW; Lu Q; Lu CL; He D; Luo Y
Ultrasound Q; 2016 Dec; 32(4):319-326. PubMed ID: 27575844
[TBL] [Abstract][Full Text] [Related]
33. Assessment of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma in Middle Eastern patients.
Sanai FM; Sobki S; Bzeizi KI; Shaikh SA; Alswat K; Al-Hamoudi W; Almadi M; Al Saif F; Abdo AA
Dig Dis Sci; 2010 Dec; 55(12):3568-75. PubMed ID: 20397051
[TBL] [Abstract][Full Text] [Related]
34. Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography.
Li R; Yang D; Tang CL; Cai P; Ma KS; Ding SY; Zhang XH; Guo DY; Yan XC
BMC Cancer; 2016 Feb; 16():158. PubMed ID: 26917546
[TBL] [Abstract][Full Text] [Related]
35. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma based on B-Mode US and CEUS.
Luo M; Liu X; Yong J; Ou B; Xu X; Zhao X; Liang M; Zhao Z; Ruan J; Luo B
Eur Radiol; 2023 Jun; 33(6):4024-4033. PubMed ID: 36484835
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of contrast-enhanced ultrasound versus computed tomography for hepatocellular carcinoma: a retrospective, single-center evaluation of 234 patients.
Schwarze V; Marschner C; Völckers W; Grosu S; Negrão de Figueiredo G; Rübenthaler J; Clevert DA
J Int Med Res; 2020 Jun; 48(6):300060520930151. PubMed ID: 32529869
[TBL] [Abstract][Full Text] [Related]
37. Predictive Value of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Early Recurrence of Hepatocellular Carcinoma after Surgical Resection.
Wang Y; Liao J; Qi W; Xie L; Li Y
Ultrasound Med Biol; 2016 May; 42(5):1042-8. PubMed ID: 26803390
[TBL] [Abstract][Full Text] [Related]
38. Contrast-enhanced ultrasound (CEUS) has excellent diagnostic accuracy in differentiating focal liver lesions: results from a Swiss tertiary gastroenterological centre.
Sawatzki M; Meyenberger C; Brand S; Semela D
Swiss Med Wkly; 2019 Jun; 149():w20087. PubMed ID: 31256416
[TBL] [Abstract][Full Text] [Related]
39. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation.
Gambarin-Gelwan M; Wolf DC; Shapiro R; Schwartz ME; Min AD
Am J Gastroenterol; 2000 Jun; 95(6):1535-8. PubMed ID: 10894592
[TBL] [Abstract][Full Text] [Related]
40. Discrimination between neoplastic and non-neoplastic lesions in cirrhotic liver using contrast-enhanced ultrasound.
Xu HX; Lu MD; Liu LN; Zhang YF; Guo LH; Xu JM; Liu C
Br J Radiol; 2012 Oct; 85(1018):1376-84. PubMed ID: 22553290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
